Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

Eleftherios Chatzimichail,1 Kristina Pfau,1,2 Zisis Gatzioufas,1 Georgios D Panos3,4 1Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland; 2Department of Ophthalmology, University Hospital Bonn, Bonn, Germany; 3Department of Ophthalmology, Queen’s Medical Centre, Nottingham...

Full description

Bibliographic Details
Main Authors:	Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-02-01
Series:	Drug Design, Development and Therapy
Subjects:	ranibizumab biosimilars age-related macular degeneration diabetic macular edema retinal disorders retinal vein occlusion cost – effectiveness
Online Access:	https://www.dovepress.com/ranibizumab-biosimilars-in-treating-retinal-disorders-a-cost-effective-peer-reviewed-fulltext-article-DDDT

Similar Items

Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion in a Real Life Practice: A Retrospective Case Series
by: Abdullah Ozkaya, et al.
Published: (2016-12-01)

Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Efficacy and prognostic factors of Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Zhi-Jun Shen, et al.
Published: (2022-10-01)

Therapeutic effects of intravitreal implantation of Dexamethasone and Ranibizumab in the treatment of retinal vein occlusion
by: Lei Shen, et al.
Published: (2022-12-01)

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
by: Xuemei Liang, et al.
Published: (2022-09-01)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Alper Halil Bayat, et al.
Published: (2019-12-01)

Intravitreous injection with ranibizumab combined laser photocoagulation for the treatment of branch retinal vein occlusion
by: Xiao-Bo Wang, et al.
Published: (2013-12-01)

Comparison of Ranibizumab alone versus Ranibizumab with Targeted Retinal Laser for Branch Retinal Vein Occlusion with Macular Oedema.
by: Mohamed Abdelmoneem, et al.
Published: (2022-10-01)

The efficacy of ranibizumab combined with 532 laser for treating retinal vein with macular edema complication
by: Dan-Na Chen, et al.
Published: (2019-03-01)

Efficacy and safety of ranibizumab combined with laser treatment in patients with BRVO and macular edema
by: Li-Bo Wang, et al.
Published: (2017-06-01)

Long-term Results of Ranibizumab, Dexamethasone Implant, and Triamcinolone in Macular Edema due to Branch Retinal Vein Occlusion
by: Nevin Hande Dikel, et al.
Published: (2019-12-01)

Micropulse laser combined with intravitreal injection of Ranibizumab in the treatment of macular edema secondary to non-ischemic branch retinal vein occlusion
by: Dan Yin, et al.
Published: (2023-11-01)

Combination of Ranibizumab and Dexamethasone intravitreal implant for macular edema secondary to retinal vein occlusion
by: Zhu Jing, et al.
Published: (2024-01-01)

Comparison of efficacy of conbercept, aflibercept, and ranibizumab ophthalmic injection in the treatment of macular edema caused by retinal vein occlusion: a Meta-analysis
by: Qiu Xing, et al.
Published: (2023-07-01)

Comparative Treatment Study on Macular Edema Secondary to Branch Retinal Vein Occlusion by Intravitreal Ranibizumab with and without Selective Retina Therapy
by: Manabu Yamamoto, et al.
Published: (2023-03-01)

Effects of different does intravitreous triamcinolone acetonide for macular edema secondary to retinal vein occlusion
by: Jing Su, et al.
Published: (2018-08-01)

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence
by: Chakraborty D, et al.
Published: (2023-04-01)

Intravitreal injection of Ranibizumab combined with laser photocoagulation for macular edema secondary to BRVO
by: Guo-Ping Wang, et al.
Published: (2018-02-01)

Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion
by: Noma H, et al.
Published: (2023-08-01)

Treatment outcomes for maculopathy secondary to retinal vein occlusion in Afghanistan
by: Mohammad Delsoz, et al.
Published: (2024-01-01)

The Dilemma between the Randomized Control Trials and Real Life Practice in the Treatment of Retinal Diseases with Intravitreal anti-VEGF agents
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor
by: Erdem Eris, et al.
Published: (2019-04-01)

A clinical trial on Conbercept for macular edema secondary to central retinal vein occlusion
by: Min Wang, et al.
Published: (2017-10-01)

Twelve-month Outcomes of Dexamethasone Implant Treatment in Macular Edema Secondary to Retinal Vein Occlusion in Real Life
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

The Major Role of Anti-Vascular Endothelial Growth Factor for Management of Macular Edema Secondary to Retinal Vein Occlusion
by: Hossam Elden Mohamed Ahmed Khalil, et al.
Published: (2021-06-01)

Comparison of efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration
by: Qiang Fan, et al.
Published: (2018-08-01)

Acute and subacute intraocular pressure and macular microvascular structure changes after intravitreal ranibizumab injection in eyes with branch retinal vein occlusion
by: Xiaoyu Li, et al.
Published: (2023-04-01)

Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
by: Ayşe Ergin, et al.
Published: (2022-12-01)

Cytokines and Pathogenesis of Central Retinal Vein Occlusion
by: Hidetaka Noma, et al.
Published: (2020-10-01)

Combination pharmacotherapy for macular edema associated with retinal vein occlusion
by: Guo Li, et al.
Published: (2019-02-01)

Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant
by: Verónica Castro-Navarro, et al.
Published: (2022-04-01)

INTRAVITREAL IMPLANT OF DEXAMETHASONE IN THE TREATMENT OF RETINAL VEIN OCCLUSION: EFFICACY AND SAFETY
by: A. E. Yavorskiy, et al.
Published: (2015-10-01)

Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association
by: V. Levent Karabaş, et al.
Published: (2022-06-01)

Changes in Neurodegeneration and Visual Prognosis in Branch Retinal Vein Occlusion after Resolution of Macular Edema
by: Chanjoon Park, et al.
Published: (2024-01-01)

Efficacy of Formulated Posterior Subtenon Triamcinolone in Macular Edema secondary to Non–Ischemic Retinal Vein Occlusions
by: Ehab Tharwat, et al.
Published: (2022-06-01)

Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion
by: Mehmet Ali Şekeroğlu, et al.
Published: (2022-08-01)

Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series
by: Debdulal Chakraborty, et al.
Published: (2022-11-01)

Visual Functions Affecting Vision-Related Quality of Life Following Intravitreal Ranibizumab Therapy for Central Retinal Vein Occlusion
by: Tomoya Murakami, et al.
Published: (2022-07-01)

Research progress of mechanism and risk factors of retinal vein occlusion
by: Li Shui, et al.
Published: (2024-01-01)

ACTION FEATURES OF THE IMPLANT WITH DEXAMETHASONE ON INDICATORS OF RETINAL VEIN OCCLUSIONS
by: M. M. Bikbov, et al.
Published: (2018-07-01)